Technology
Health
Biotechnology

VBI Vaccines

$2.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.50%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VBI Vaccines and other stocks, options, ETFs, and crypto commission-free!

About

VBI Vaccines, Inc. New Common Stock (Canada), also called VBI Vaccines, is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. Read More Its pipeline include HBV Therapeutic,HBV Prophylaxis, CMV Propylaxis, GBM Immunotherapy, MB Immunotherapy, and Zika Propylaxis. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

Employees
112
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
198.25M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
367.14K
High Today
$2.04
Low Today
$1.97
Open Price
$2.00
Volume
103.76K
52 Week High
$3.95
52 Week Low
$1.14

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2016 IPO
US
North America

News

Yahoo FinanceMay 1

VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Tops Revenue Estimates

Fortis (FTS) delivered earnings and revenue surprises of -1.79% and 6.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

94
Yahoo FinanceApr 30

VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

VBI Vaccines, Inc. (VBIV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, ...

44

Earnings

-$0.28
-$0.24
-$0.19
-$0.15
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.